TP53, CDKN2A, and RB1 are the most frequently altered genes in soft tissue sarcomas, with TP53 mutations and CDKN2A/RB1 copy number losses playing pivotal roles in tumor progression and prognosis. This evidence concerns the gene RB1 and neoplasm.